Zilli, T. Et Al. 2020. Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.. Cancer medicine , vol.9, no.9 , 3097-3106.

Zilli, T., Jorcano, S., Bral, S., Rubio, C., Bruynzeel, A., Oliveira, A., ... Abacioglu, U.(2020). Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.. Cancer medicine , vol.9, no.9, 3097-3106.

Zilli, T Et Al. "Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.," Cancer medicine , vol.9, no.9, 3097-3106, 2020

Zilli, T Et Al. "Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.." Cancer medicine , vol.9, no.9, pp.3097-3106, 2020

Zilli, T. Et Al. (2020) . "Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.." Cancer medicine , vol.9, no.9, pp.3097-3106.

@article{article, author={T Zilli Et Al. }, title={Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.}, journal={Cancer medicine}, year=2020, pages={3097-3106} }